KNOWLEDGE AND PRACTICE OF CONTRACEPTIVES AMONG FEMALE STUDENTS IN DELTA STATE UNIVERSITY, ABRAKA
Access to contraceptive has become increasingly crucial for adolescents because many are sexually active at earlier ages than in the past. This will further compound overall levels of maternal mortality in Nigeria tertiary institutions.This research was specifically designed to determine the knowledge and utilization of contraceptives among female students in Delta State University, Abraka. A total of 107 questionnaires were distributed and 97 were retrieved. majority of respondents were within the age bracket of 20-24 years of 35.1%. 79.4 % of the respondents were single. More than half (95%) of the respondents knew about contraceptives.reason for the lack of detailed knowledge on this subject may be linked to the sources of information; majority of the students got to know about contraception from their friends/peers (39.2%). The study disclosed that there is a high number of females students who practiced sexual intercourse which may result into unintended pregnancy. Also revealed that there is a low trend of use of modern contraceptives for inadequate knowledge. It is therefore recommended that the use of contraceptives amongst undergraduate female students that are attributed to esteem and habit of students should be reviewed for preferred methods and legally backed practice and use of contraceptives by undergraduates.
UNAIDS (2007) estimated that 33.2 million women had HIV infection worldwide. In many regions of the world more women than men are at risk of HIV infection with not less 50% of all new daily infections in sub-Saharan Africa being in women. Children account for 12% of all new infections and globally 2.5 million children less than 15years of age were living with HIV in 2007, about 1,200 children under the age of 15years became infected with HIV daily (UNAID/WHO, 2007), without appropriate care and treatment, more than 50% of newly infected children will die before the second birthday. In 2008, around 430,000 children under 15years become infected with HIV, mainly through mothers –to child transmission (MTCT), infection occurred in Africa where AIDS is beginning to reverse decades of steady progress in child survival. In high income countries MTCT has been virtually eliminated thanks to effective HIV counseling and testing, access to antiresonator therapy ART, Safe delivery practices, and the widespread availability and safe use of breast-milk substitutes. If these interventions were used worldwide, they could save the lives of thousands of children each year. Owing to the translatability of HIV from mother to child, the feeding of HIV-exposed infants remains a significant challenge in controlling the spread of HIV/AIDS. The dilemma concerning feeding infants of HIV positive mothers is how to balance the risk of HIV transmission through breastfeeding with the risk of death from causes other than HIV such as pneumonia, diarrhea diseases and malnutrition among formula-fed infants (WHO, 2010). Exclusive breastfeeding (EBF) plays a critical role in the overall health of infants. It is estimated that 3% of all under-5 mortalities in low-income countries could be prevented through optimal breastfeeding during the crucial first year of life (WHO, 2013). Optimal breastfeeding is considered to be EBF for the first 6 months of life, followed by continued breastfeeding combined with safe and nutritionally adequate complementary feeding up to 24 months of age (WHO, 2009).EBF is regarded as a global health goal given its strong association with reduced morbidity and mortality, particularly in low-income countries where safe water and sanitation are oen lacking. The HIV/AIDS epidemic is one of the major factors challenging women’s health with 20 million women living with the virus and more than 2 million pregnancies occurring in HIV positiveness women annually. Thus, HIV infection has become a major problem complicating the management of pregnancy. In Africa, HIV prevalence varies considerably, with most countries in Southern Africa having more than one in five pregnant women infected, and in a few sub-Saharan countries, median HIV prevalence in antenatal clinics in 2003 exceeded 10% (McIntyre,2005). As at 2005 the prevalence in Nigeria was 4. 4%, and by the end of 2006, it was estimated that there are 2. 99 million Nigerians living with HIV, with 305, 080 adult new infections and 74, 520 in children, largely (up to 90%) acquired through mother to-child transmission (MTCT). Between 25 and 44% of mother-to-child transmission (MTCT) of HIV occurs through breastfeeding (FMOH, 2007) The promotion of breastfeeding is a key component of infant health polices globally because of its obvious health benefits. It is widely practiced not only in Nigeria, but most
students/knowledge-and-practice-of-contraceptives-among-female-student of Africa, as it is socially and culturally acceptable and natural. However, in the present context of HIV epidemic, this has become a public health dilemma as the overwhelming source of HIV infection in young children is through MTCT (FMOH, 2007). There is also the dilemma of infant feeding decisions by HIV seropositive
mothers, because most breast milk transmission of HIV- 1 occurs in the first four months of life, a time when replacement feeding carries the greatest risk of increasing infectious disease morbidity and the benefits of the breastfeeding are highest. In developing countries, decisions regarding the best mode
of infant feeding can be difficult due to social, economic and practical constraints. The relative risks of morbidity and mortality associated with replacement feeding vary according to many factors: the environment, individual circumstances of the mother and her family including her education and economic status (WHO, 2004). The WHO/UNAIDS strategic response to prevention of HIV infection in infants centered on four ‘pillars’: primary prevention of infection generally in women, prevention of transmission from HIV infected women to their infants and provision of treatment, care and support to HIV infected
women and their families (WHO, 2004) .